Literature DB >> 22314670

Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation.

Gustavo Lopera1, Gerald A Beathard, Jose Exaire, Roger Carrillo.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22314670     DOI： 10.1007/s10840-011-9649-y

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  34 in total

1.  Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).

Authors:  Bruce L Wilkoff; Charles J Love; Charles L Byrd; Maria Grazia Bongiorni; Roger G Carrillo; George H Crossley; Laurence M Epstein; Richard A Friedman; Charles E H Kennergren; Przemyslaw Mitkowski; Raymond H M Schaerf; Oussama M Wazni
Journal:  Heart Rhythm       Date:  2009-05-22       Impact factor: 6.343

2.  Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads.

Authors:  D Paniagua; H R Aldrich; E H Lieberman; G A Lamas; A S Agatston
Journal:  Am J Cardiol       Date:  1998-11-01       Impact factor: 2.778

3.  Mortality caused by sepsis in patients with end-stage renal disease compared with the general population.

Authors:  M J Sarnak; B L Jaber
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

4.  Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery.

Authors:  Heather Bloom; Brian Heeke; Angel Leon; Fernando Mera; David Delurgio; John Beshai; Jonathan Langberg
Journal:  Pacing Clin Electrophysiol       Date:  2006-02       Impact factor: 1.976

Review 5.  Infections of electrophysiologic cardiac devices.

Authors:  Daniel Z Uslan
Journal:  Expert Rev Med Devices       Date:  2008-03       Impact factor: 3.166

6.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Authors:  Larry M Baddour; Andrew E Epstein; Christopher C Erickson; Bradley P Knight; Matthew E Levison; Peter B Lockhart; Frederick A Masoudi; Eric J Okum; Walter R Wilson; Lee B Beerman; Ann F Bolger; N A Mark Estes; Michael Gewitz; Jane W Newburger; Eleanor B Schron; Kathryn A Taubert
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

7.  Risk factors for mortality in patients with cardiac device-related infection.

Authors:  Timir S Baman; Sanjaya K Gupta; Javier A Valle; Elina Yamada
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02-13

8.  Nontraditional implantable cardioverter defibrillator placement in adult patients with limited venous access: a case series.

Authors:  Mayurkumar Bhakta; Chedozie C Obioha; Dan Sorajja; Komadoor Srivathsan; Francisco A Arabia; Patrick A Devaleria; Dawn E Jaroszewski; Luis R Scott; Gregory T Altemose
Journal:  Pacing Clin Electrophysiol       Date:  2009-10-05       Impact factor: 1.976

9.  Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement.

Authors:  Lars Lickfett; Alexander Bitzen; Aravind Arepally; Khurram Nasir; Christian Wolpert; Kyung Mi Jeong; Ulf Krause; Rainer Schimpf; Thorsten Lewalter; Hugh Calkins; Werner Jung; Berndt Lüderitz
Journal:  Europace       Date:  2004-01       Impact factor: 5.214

10.  Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators.

Authors:  D P Zipes; D Roberts
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.